Brief: Enorama Pharma Q3 operating loss widens to SEK 2.1 mln
15/11/2017 06:46
Nov 15 (Reuters) - ENORAMA PHARMA AB ERMA.ST :
* Q3 OPERATING LOSS SEK 2.1 MILLION VERSUS LOSS SEK 1.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr1H7x43
Further company coverage: ERMA.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Enorama Pharma AB
See all newsBrief: Enorama Pharma Signs Agreements For Nic-S Tobacco-Free White Snus
Brief: Enorama Pharma Gets FDA Statement In Ongoing US Court Proceedings
Brief: Enorama Pharma Q2 Operating Loss SEK 11.7 Mln
Brief: FDA Upholds Refuse-To-File Decision On Enorama Pharma's PMTA Applications
Brief: Enorama Pharma Names Amy Walker New Interim CEO